Renaissance Technologies’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-171,911
| Closed | -$1.09M | – | 4540 |
|
|
2022
Q4 | $1.09M | Sell |
171,911
-49,600
| -22% | -$275K | ﹤0.01% | 2485 |
|
|
2022
Q3 | $1.13M | Buy |
221,511
+54,100
| +32% | +$340K | ﹤0.01% | 2417 |
|
|
2022
Q2 | $1.05M | Sell |
167,411
-81,729
| -33% | -$275K | ﹤0.01% | 2684 |
|
|
2022
Q1 | $884K | Sell |
249,140
-40,271
| -14% | -$149K | ﹤0.01% | 2810 |
|
|
2021
Q4 | $1.45M | Buy |
289,411
+170,000
| +142% | +$1.03M | ﹤0.01% | 2389 |
|
|
2021
Q3 | $874K | Sell |
119,411
-27,600
| -19% | -$189K | ﹤0.01% | 2621 |
|
|
2021
Q2 | $1.26M | Buy |
147,011
+8,700
| +6% | +$74.2K | ﹤0.01% | 2547 |
|
|
2021
Q1 | $1.5M | Sell |
138,311
-43,478
| -24% | -$422K | ﹤0.01% | 2408 |
|
|
2020
Q4 | $1.79M | Buy |
181,789
+52,519
| +41% | +$344K | ﹤0.01% | 2183 |
|
|
2020
Q3 | $693K | Buy |
129,270
+11,137
| +9% | +$66.7K | ﹤0.01% | 2691 |
|
|
2020
Q2 | $695K | Buy |
118,133
+33,901
| +40% | +$196K | ﹤0.01% | 2730 |
|
|
2020
Q1 | $313K | Buy |
84,232
+33,999
| +68% | +$176K | ﹤0.01% | 2960 |
|
|
2019
Q4 | $317K | Buy |
50,233
+12,783
| +34% | +$162K | ﹤0.01% | 3059 |
|
|
2019
Q3 | $515K | Buy |
37,450
+4,650
| +14% | +$76.6K | ﹤0.01% | 2863 |
|
|
2019
Q2 | $484K | Buy |
32,800
+23,575
| +256% | +$631K | ﹤0.01% | 3010 |
|
|
2019
Q1 | $387K | Buy |
9,225
+1,600
| +21% | +$67.4K | ﹤0.01% | 3024 |
|
|
2018
Q4 | $317K | Buy |
7,625
+425
| +6% | +$19.1K | ﹤0.01% | 3011 |
|
|
2018
Q3 | $347K | Buy |
7,200
+3,325
| +86% | +$167K | ﹤0.01% | 2971 |
|
|
2018
Q2 | $184K | Buy |
+3,875
| New | +$215K | ﹤0.01% | 3087 |
|
|
2017
Q4 | – | Sell |
-8,471
| Closed | -$571K | – | 3550 |
|
|
2017
Q3 | $571K | Sell |
8,471
-55
| -0.6% | -$3.15K | ﹤0.01% | 2756 |
|
|
2017
Q2 | $462K | Buy |
+8,526
| New | +$395K | ﹤0.01% | 2783 |
|
Renaissance Technologies's FSTX Position: Q1 2023 in Review
Renaissance Technologies sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 171,911 shares — an estimated $1.09M sold.
Renaissance Technologies first reported a position in FSTX in Q2 2017 and held it in 21 quarters. The position peaked at $1.79M in Q4 2020. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.
- Renaissance Technologies reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
- Renaissance Technologies sold 171,911 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $1.09M.
- Renaissance Technologies first reported a position in F-star Therapeutics, Inc. Common Stock in Q2 2017 and held it in 21 quarters.
- Renaissance Technologies's F-star Therapeutics, Inc. Common Stock position peaked at $1.79M in Q4 2020.
- 0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.
Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.